Fate of contaminating t(14;18)+ lymphoma cells during ex vivo expansion of CD34-selected hematopoietic progenitor cells

Blood

Volumn 88, Issue 8, 1996, Pages 3166-3175

  Widmer, Lucas ^a   Pichert, Gabriella ^a   Jost, Lorenz Michael ^a   Stahel, Rolf Arno ^a,b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b Division of Oncology   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; INTERLEUKIN 1BETA; INTERLEUKIN 3; INTERLEUKIN 6;

ADULT; ANIMAL CELL; ANTIGEN PRESENTING CELL; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; HEMATOPOIESIS; HODGKIN DISEASE; HUMAN; IMMUNOADSORPTION; NONHODGKIN LYMPHOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STEM CELL;

EID: 0029973965     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.8.3166.bloodjournal8883166     Document Type: Article

References (40)

1. Appelbaum FR, Herzig GP, Ziegler JL. Graw RG, Levine AS, Deisseroth AB: Successful engraftment of cryopreserved autologous bone marrow in patients with malignant lymphoma. Blood 52:85, 1978
2. Kessinger A, Armitage JO: The evolving role of autologous peripheral stem cell transplantation following high-dose therapy for malignancies. Blood 77:211, 1991
3. Moss TJ, Sanders DG, Lasky LC, Bostrom B: Contamination of peripheral blood stem cell harvests by circulating neuroblastoma cells. Blood 76:1879, 1990
4. Ross AA, Cooper BW, Lazarus HM, Mackay W, Moss TJ, Ciobanu N, Tallman MS, Kennedy MJ, Davidson NE, Sweet D, Winter C, Akard L, Jansen J, Copelan E, Meagher RC, Herzig RH, Klumpp TR, Kahn DG, Warner NE: Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques. Blood 82:2605, 1993
5. Gribben JG, Neuberg D, Freedman AS, Gimmi CD, Pesek KW, Barber M, Saporito L, Woo SD, Coral F, Spector N, Rabinowe SN, Grossbard ML, Ritz J, Nadler LM: Detection by polymerase chain reaction of residual cells with the bcl-2 translocation is associated with increased risk of relapse after autologous bone marrow transplantation for B-cell lymphoma. Blood 81:3449, 1993
6. Brenner MK, Rill DR, Moen RC, Krance RA, Mirro J, Anderson WF, Ihle JN: Gene-marking to trace origin of relapse after autologous bone-marrow transplantation. Lancet 341:85, 1993
7. Gribben JG, Freedman AS, Neuberg D, Roy DC, Blake KW, Woo SD, Grossbard ML, Rabinowe SN, Coral F, Freeman GJ, Ritz J, Nadler LM: Immunologic purging of marrow assessed by PCR before autologous bone marrow tranplantation for B-cell lymphoma. N Engl J Med 325:1525, 1991
8. + marrow cells for autologous marrow transplantation, in Dicke KA, Spitzer G, Jagannath S, Evinger-Hodges MJ (eds): Autologous Bone Marrow Transplantation: Proceedings of the Fourth International Symposium. Houston, TX, MD Anderson Hospital, 1989, p 55
9. + cells and unseparated peripheral blood progenitor cells mediate indentical hematopoietic engraftment after high-dose VP16, Ifosfamide, Carboplatin, and Epirubicin. Blood 84:1421, 1994
10. Shpall EJ, Jones RB, Bearman SI, Franklin WA, Archer PG, Curiel T, Bitter M, Claman HN, Stemmer SM, Purdy M, Myers SE, Hami L, Taffs S, Heimfeld S, Hallagan J, Berenson RJ: Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: Influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment. J Clin Oncol 12:28, 1994
11. Koller MR, Emerson SG, Palsson BO: Large-scale expansion of human stem and progenitor cells from bone marrow mononuclear cells in continuous perfusion cultures. Blood 82:378, 1993
12. + cells into the myeloid lineage. Blood 80:1405, 1992
13. + progenitor cells by stem cell factor, interleukin-1β (IL-1β), IL-6, IL-3, interferon-γ, and erythropoietin. Blood 81:2579, 1993
14. + cells from patients with stage IV breast cancer. Blood 84:3567, 1994
15. Brugger W, Heimfeld S, Berenson RJ, Mertelsmann R, Kanz L: Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo. N Engl J Med 333:283, 1995
16. Bregni M, Magni M, Siena S, Di Nicola M, Bonadonna G, Gianni AM: Human peripheral blood hematopoietic progenitors are optimal targets of retroviral-mediated gene transfer. Blood 80:1418, 1992
17. Gribben JG, Freedman AS, Woo SD, Blake K, Shu RS, Freeman G, Longtine JA, Pinkus GS, Nadler LM: All advanced stage non-Hodgkin's lymphomas with a polymerase chain reaction amplifiable breakpoint of bcl-2 have residual cells containing the bcl-2 rearrangement at evaluation and after treatment. Blood 78:3275, 1991
18. Negrin RS, Kiem HP, Schmidt-Wolf IGH, Blume KG, Cleary ML: Use of the polymerase chain reaction to monitor the effectiveness of ex vivo tumor cell purging. Blood 77:654, 1991
19. Gribben JG, Saporito L, Barber M, Blake KW, Edwards RM, Griffin JD, Freedman AS, Nadler LM: Bone marrows of non-Hodgkin's lymphoma patients with a bcl-2 translocation can be purged of polymerase chain reaction-detectable lymphoma cells using monoclonal antibodies and immunomagnetic bead depletion. Blood 80:1083, 1992
20. Jones HM, Jones SA, Watts MJ, Khwaja A, Mills W, Fielding A, Goldstone AH, Lincn DC: Development of a simplified single-apheresis approach for peripheral-blood progenitor-cell transplantation in previously treated patients with lymphoma. J Clin Oncol 12:1693, 1994
21. Sutherland HJ, Eaves AC, Eaves CJ: Quantitative assays for human hematopoietic progenitor cells: in Gee AP (ed): Bone Marrow Processing and Purging: A Practical Guide. Boca Raton, FL, CRC, 1991, p 155
22. Pontvert-Delucq S, Breton-Gorius J, Schmitt C, Baillou C, Guichard J, Najman A, Lemoine FM: Characterization and functional analysis of adult human bone marrow cell subsets in relation to B-lymphoid development. Blood 82:417, 1993
23. Bender JG, Unverzagt K, Walker DE, Lee W, Smith S, Williams S, Van Epps DE: Phenotypic analysis and characterization of CD34+ cells from normal human bone marrow, cord blood, peripheral blood, and mobilized peripheral blood from patients undergoing autologous stem cell transplantation. Clin Immunol Immunopathol 70:10, 1994
24. Becker-André M, Hahlbrock K: Absolute mRNA quantification using the polymerase chain reaction (PCR). A novel approach by using a PCR aided transcript titration assay (PATTY). Nucleic Acids Res 17:9437, 1989
25. Lion T, Izraeli S, Henn T, Gaiger A, Mor W, Gadner H: Monitoring of residual disease in chronic myelogenous leukemia by quantitative polymerase chain reaction. Leukemia 6:495, 1992
26. Cross NCP: Quantitative PCR techniques and applications. Br J Haematol 89:693, 1995
27. Gilliland G, Perrin S, Bunn HF: Competitive PCR for quantitation of mRNA, in Innis M (ed): PCR Protocols: A Guide to Methods and Applications. New York, NY, Academic, 1990, p 61
28. Williams DA, Hsieh K, Desilva A, Mulligan RC: Protection of bone marrow transplant recipients from lethal doses of methotrexate by the generation of methotrexate-resistant bone marrow. J Exp Med 166:210, 1987
29. Hanania EG, Wang T, Zu Z, Berenson R, Heimfeld S, Giles R, Kavanagh J, Deisseroth AB: Methods for assessment of the efficiency of gene therapy in a genetic chemoprotection clinical trial for ovarian cancer using the multiple drug resistance (MDR1) gene in a safety-modified retroviral vector. Proc Am Soc Clin Oncol 14:592a, 1995
30. + bone marrow progenitor cells in patients with non-Hodgkin's lymphoma. Blood 85:1647, 1995
31. + marrow cells for autologous marrow transplantation. Hematol Oncol Ann 2:78, 1994
32. + progenitors in bone marrow of BCL2-IgH-positive follicular lymphoma patients. Blood 86: 4691, 1995
33. Bertoli LF, Kubagawa H, Borzillo GV, Burrows PD, Schreeder MT, Carroll AJ, Cooper MD: Bone marrow origin of a B-cell lymphoma. Blood 72:94, 1988
34. + progenitor cells. Blood 86:295a, 1995 (abstr, suppl 1)
35. + blood cells: No evidence for tumor cell expansion in multiple myeloma. Blood 86:62a, 1995 (abstr, suppl 1)
36. + cells in autologous stem cell transplantation for breast cancer. Blood 87:1687, 1996
37. Peters SO, Kittler ELW, Ramshaw HS, Quesenberry PJ: Diminished potential of in vitro expanded hematopoietic progenitors in active cell cycle for long-term repopulation of irradiated hosts. Blood 86:462a, 1995 (abstr, suppl 1)
38. Holyoake TL, Alsorn MJ, Richmond L, Pearson C, Farrell E, Kyle B, Dunlop DJ, Fitzsimons E, Steward WP, Pragnel IB, Franklin IM: A phase I study to evaluate the safety of re-infusing CD34 cells expanded ex vivo as part or all of a PBPC transplant. Blood 86:294a, 1995 (abstr, suppl 1)
39. Juliusson G: Hematopoietic reconstitution with autologous stem cells. N Engl J Med 334:271, 1996 (letter)
40. +-selected and immunomagnetically purged hematopoietic progenitor cells mediates rapid hematological recovery after high-dose chemotherapy in patients with follicular lymphoma. Blood 86:232a, 1995 (abstr, suppl 1)